Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01322165 · ClinicalTrials.gov registry record
National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 3,706
- Enrollment target
NCT01322165 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 3,706 participants.
The verdict
NCT01322165 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 3,706 participants
- Enrollment target
Study Summary
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) was initiated in 2006 by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). GenTAC established a registry of 3706 patients with genetic conditions that may be related to thoracic aortic aneurysms and collected medical data and biologic samples. The study ended in September 2016. Data and samples are available from NHLBI and requests should be made to BioLINCC. See the NHLBI website for more information: https://www.nhlbi.nih.gov/research/resources/gentac/.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,706 participants |
| Start Date | 2007-11 |
| Est. Completion | 2016-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01322165
The ClinicalTrials.gov registry entry for NCT01322165 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,706 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01322165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01322165 about?
NCT01322165 is a clinical study titled "National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions". The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) was initiated in 2006 by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). GenTAC established a r...
What is the current status of trial NCT01322165?
This trial is currently completed. The enrollment target is 3,706 participants. The study started on 2007-11. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01322165?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.